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The adaptor protein Bcl10 is a critically important
mediator of T cell receptor (TCR)-to-NF-kB signaling.
Bcl10 degradation is a poorly understood biological
phenomenon suggested to reduce TCR activation
of NF-kB. Herewe have shown that TCR engagement
triggers the degradation of Bcl10 in primary effector
T cells but not in naive T cells. TCR engagement
promoted K63 polyubiquitination of Bcl10, causing
Bcl10 association with the autophagy adaptor p62.
Paradoxically, p62 binding was required for both
Bcl10 signaling to NF-kB and gradual degradation
of Bcl10 by autophagy. Bcl10 autophagy was highly
selective, as shown by the fact that it spared Malt1,
a direct Bcl10 binding partner. Blockade of Bcl10
autophagy enhanced TCR activation of NF-kB.
Together, these data demonstrate that selective
autophagy of Bcl10 is a pathway-intrinsic homeo-
static mechanism that modulates TCR signaling to
NF-kB in effector T cells. This homeostatic process
may protect T cells from adverse consequences of
unrestrained NF-kB activation, such as cellular
senescence.
INTRODUCTION
Antigen stimulation of the T cell receptor (TCR) initiates a
complex signaling cascade, culminating in the initiation of
a transcriptional program, which drives T cell proliferation and
differentiation. The NF-kB transcription factor is a particularly
important target of TCR signaling, playing a central role in driving
entry into cell cycle via stimulating transcription of numerous
effector molecules, including interleukin-2 (IL-2) (Skaug et al.,
2009; Vallabhapurapu and Karin, 2009). The adaptor protein
Bcl10 plays a key role in transmitting signals from the TCR to
NF-kB. In the absence of Bcl10, T cells are unable to efficiently
proliferate and differentiate in response to TCR engagement
(Ruland et al., 2001; Schulze-Luehrmann and Ghosh, 2006;
Thome et al., 2010).
Previous studies have suggested that a TCR-dependent
mechanism targets Bcl10 for proteolysis, in concert with activa-tion of NF-kB. Although these studies suggested that Bcl10
degradation may be a mechanism to limit TCR signals to
NF-kB, the data supporting such a model are limited. Addition-
ally, the molecular mechanism of Bcl10 degradation remains
highly controversial, with different groups publishing data sup-
porting diverse degradatory mechanisms (Hu et al., 2006; Lobry
et al., 2007; Scharschmidt et al., 2004; Wu and Ashwell, 2008;
Zeng et al., 2007). Also, almost all experiments in previous
studies were performed with long-term tumor cell lines, such
as Jurkat. It is therefore unclear to what extent the phenomenon
of Bcl10 degradation is relevant to the biology of primary
T cells.
Macroautophagy (henceforth termed autophagy) is a cellular
process by which cytosolic constituents are engulfed in
double-membrane encapsulated vesicles, followed by delivery
to lysosomes for degradation. Autophagy can serve as a survival
mechanism under conditions of metabolic starvation and growth
factor withdrawal, via nonselective degradation of cytosolic
constituents for reuse (Chaturvedi and Pierce, 2009; Lu¨nemann
and Mu¨nz, 2009). Emerging evidence suggests that autophagy
can also target specific proteins for destruction. Specifically,
data suggest that this specialized type of autophagy, referred
to as selective autophagy, can target specific proteins or organ-
elles for degradation. In general, proteins enter the selective
autophagy pathway after posttranslational modification with
K63-polyubiquitin chains. K63-polyubiquitinated proteins are
then bound by p62 (also called SQSTM-1) or by functionally
related autophagy adaptor proteins, followed by engulfment in
autophagosomes (Kirkin et al., 2009b; Kraft et al., 2010; Levine
et al., 2011).
Interestingly, recent data have shown that TCR stimulation
induces autophagy (Li et al., 2006), that autophagy contributes
to T cell survival and antigen-dependent proliferation (Pua et al.,
2007), and that autophagy-deficient T cells produce more
interleukin-2 (IL-2) than their wild-type counterparts (Jia et al.,
2011). These data suggest that TCR-dependent autophagy limits
the production of T cell effector molecules such as IL-2 that are
essential mediators of T cell proliferative responses. However,
the mechanistic link between TCR-induced autophagy and the
modulation of T cell effector responses remains to be deter-
mined. In this study, we have established that Bcl10 is degraded
via selective autophagy, reducing TCR activation of NF-kB
and limiting NF-kB-dependent effector responses. This study
therefore implicates selective autophagy as a mechanism that
modulates antigen receptor signaling and, more generally, asImmunity 36, 947–958, June 29, 2012 ª2012 Elsevier Inc. 947
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Figure 1. T Cell Activation Leads to Bcl10 Colocalization with Markers of the Autophagy-Lysosomal Degradation System and Subsequent
Bcl10 Degradation
(A) D10 T cells expressing Bcl10-CFP and MALT1-YFP were stimulated with anti-CD3 for 20 min and stained with antibodies to the indicated autophagosome
markers to assess colocalization.
(B) Pearson coefficient analysis was calculated by intensity correlation analysis of Bcl10-CFP fluorescence with MALT1-YFP fluorescence (white bar) or with
fluorescence from antibodies specific for the indicated vesicular makers (black bars). For Pearson coefficient analysis, at least 30 cells were measured in each
group. Values are means; error bars indicate SEM.
(C) D10 T cells expressing RFP-LC3, Bcl10-CFP, and MALT1-YFP were stimulated with anti-CD3 and assessed by confocal microscopy for colocalization.
(D) Primary naive and effector T cells were stimulated with anti-CD3+anti-CD28 for the indicated times. Lysates were analyzed by immunoblotting for Bcl10
degradation. Blots were also probed with anti-a-tubulin as a loading control. Data are representative of two experiments.
(E) CD4+ Th2 cells and CD8+ Tcm cells expressing Bcl10-GFP were stimulated for the indicated times with anti-CD3+anti-CD28. Flow cytometry was used to
assess Bcl10-GFP degradation. Values are median Bcl10-GFP fluorescence (error bars, SEM), generated from three independent experiments. Representative
flow cytometry histograms are shown in Figure S1C.
(F and G) Primary effector T cells expressing Bcl10-GFP were stimulated with anti-CD3+anti-CD28 for the indicated times. Cells were stained with anti-CD4 or
anti-CD8 to identify cell lineage (F) or with anti-LC3 and anti-ATG12 to assess colocalization with Bcl10-GFP (G).
Images are representative of two independent experiments. Scale bars represent 10 mm. See also Figure S1.
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initiated signaling cascade.
RESULTS
Bcl10 Associates with Autophagosomes after TCR
Stimulation
Our previous microscopy studies demonstrated that TCR
signaling leads to oligomerization of Bcl10 and Malt1, forming
punctate cytosolic structures called POLKADOTS, which may948 Immunity 36, 947–958, June 29, 2012 ª2012 Elsevier Inc.include a vesicular component (Rossman et al., 2006). To identify
vesicular structures associated with POLKADOTS, we used
anti-CD3 to activate D10 T cells expressing Bcl10-cyan fluores-
cent protein (CFP) and MALT1-yellow fluorescent protein (YFP).
We also stained these T cells with antibodies directed against a
variety of intracellular vesicle markers. Confocal microscopy
analysis showed that LC3 and ATG12, markers for auto-
phagosomes, closely colocalized with Bcl10 and MALT1 in
POLKADOTS (Figure 1A). Pearson’s colocalization analysis
showed higher correlation between Bcl10 and LC3 compared
Immunity
Autophagy Regulates TCR Activation of NF-kBto the other vesicular markers (Figure 1B). Notably, Lamp2,
a lysosomal marker, also showed increased colocalization with
POLKADOTS (Figure 1B).
To confirm that autophagosomes associatewithPOLKADOTS,
we stably expressed a red fluorescent protein (RFP)-LC3
recombinant protein in D10 cells. At 20 min postactivation, D10
T cells showed induction of punctate cytosolic RFP-LC3 signals,
representing TCR-induced autophagosomes (Li et al., 2006).
RFP-LC3+ autophagosomes colocalized with cytosolic Bcl10-
and MALT1-containing POLKADOTS (Figure 1C). At 120 min,
the Bcl10-CFP signal was lost, reflecting postactivation Bcl10
degradation (Hu et al., 2006; Lobry et al., 2007; Scharschmidt
et al., 2004; Wu and Ashwell, 2008; Zeng et al., 2007), and
the remaining MALT1-YFP was coalesced into one or several
large aggregated structures. Together, these colocalization
data suggest that POLKADOTS interact with vesicles of the
autophagy-lysosomal degradation system.
Bcl10 Degradation Occurs in Effector T Cells but Not
in Naive T Cells
To assess whether or not Bcl10 degradation occurs in primary
T cells, we purified CD4+ and CD8+ T cells from C57BL/6 mice.
Cells were stimulated with anti-CD3+anti-CD28 and analyzed
by immunoblotting to measure Bcl10. We observed no change
in Bcl10 at 0 and 2 hr poststimulation and increased Bcl10 by
24 hr stimulation (Figure 1D). To reconcile this lack of Bcl10
degradation in stimulated naive primary T cells with the clear
Bcl10 degradation observed in D10 T cells by our group (Fig-
ure 1C and data not shown) and in the Jurkat T cell line and addi-
tional cell types by others (Hu et al., 2006; Lobry et al., 2007;
Scharschmidt et al., 2004; Wu and Ashwell, 2008; Zeng et al.,
2007), we hypothesized that Bcl10 degradation might be a
function of T cell differentiation, as indicated by the fact that
D10 is a terminally differentiated Th2 cell clone. To test this
hypothesis, we in vitro differentiated CD4+ Th2 effector cells
and CD8+ Tcm cells (Figures S1A and S1B available online).
These differentiated effectors were then restimulated with anti-
CD3+anti-CD28 and Bcl10 degradation was assessed via immu-
noblotting. Both CD4+ Th2 cells and CD8+ Tcm cells showed
reduced Bcl10 at 2 hr compared to unstimulated T cells (Fig-
ure 1D). As a second assay to confirm Bcl10 degradation in
primary effector cells, we expressed Bcl10-GFP in CD4+ Th2
and CD8+ Tcm cells. Flow cytometry analysis showed reduced
median fluorescence of Bcl10-GFP at 2 hr after anti-CD3+anti-
CD28 stimulation in both effector cell types (Figures 1E
and S1C).
We next examined Bcl10 redistribution in primary effector
T cells. We stimulated CD4+ Th2 cells for 0 and 20 min, followed
by antibody staining and confocal microscopy to visualize
endogenous Bcl10. This analysis showed that Bcl10 exhibited
a diffuse distribution in the absence of stimulation, whereas it
formed distinct cytosolic clusters after 20 min of anti-CD3+
anti-CD28 stimulation (Figure S1D). Therefore, endogenous
Bcl10 and Bcl10-GFP show highly similar redistribution patterns
in primary T effector cells.
Using CD4+ Th2 and CD8+ Tcm cells infected with a Bcl10-
GFP retrovirus, we then performed an anti-CD3+anti-CD28
stimulation time course. Via confocal microscopy analysis, we
observed formation of Bcl10-GFP cytosolic clusters at 20 min,followed by substantial Bcl10-GFP degradation at 2 hr (Fig-
ure 1F). Also, Bcl10-GFP clusters colocalized with the autopha-
gosomemarkers LC3 and ATG12 (Figure 1G), consistent with the
D10 T cell phenotype (Figure 1C). Bcl10-GFP colocalization with
ATG12 also occurred in response to D10 T cell stimulation by
cognate antigen presented by an antigen-presenting cell (APC)
(Figure S1E). Finally, autophagosome association with Bcl10
was not associated with induction of apoptosis or other mecha-
nisms of cell death, as shown by the fact that there was minimal
activation of caspase 3 (Figure S1F) in stimulated D10 T cells.
Moreover, the fraction of stimulation-induced cell death was
<5% during the first 2 hr of anti-CD3 stimulation, increasing to
only 7% by 8 hr poststimulation (Figure S1G). Together, the
data in Figure 1 demonstrate that effector, but not naive, T cells
degrade Bcl10 in response to TCR stimulation. Additionally,
TCR-dependent Bcl10 degradation is temporally correlated
with close spatial association between Bcl10 cytosolic clusters
(POLKADOTS) and autophagosomes. These data suggest that
POLKADOTS may be a site of Bcl10 degradation via autophagy.
TCR Stimulation Triggers K63 Polyubiquitination of
Bcl10 and Bcl10-p62 Physical Association
Although signals for selective autophagy of individual proteins
are not yet completely understood, both monoubiquitination
and K63 polyubiquitination can target proteins for autophagy,
whereas K48-polyubiquitinated proteins are typically degraded
by the proteasome (Kirkin et al., 2009b; Kraft et al., 2010). A
previous study reported that Bcl10 is modified by both K63-
and K48-polyubiquitin chains after TCR stimulation (Wu and
Ashwell, 2008). To assess whether one or more proteins in
POLKADOTS are modified by polyubiquitin, we stained anti-
CD3-stimulated D10 T cells with a general antibody against poly-
ubiquitin, as well as with antibodies specific for either K48 or K63
polyubiquitin. Confocal microscopy showed that POLKADOTS
contained polyubiquitinated proteins. Furthermore, the K63-
polyubiquitin antibody intensely labeled the POLKADOTS,
whereas the anti-K48-polyubiquitin staining was primarily con-
fined to the nucleus, demonstrating that proteins within
POLKADOTS are primarily modified by K63-polyubiquitin chains
(Figure 2A). To assess whether Bcl10 is directly K63 polyubiqui-
tinated in D10 T cells, we immunoprecipitated Bcl10-GFP (after
boiling in SDS) via a GFP antibody. Immunoblotting with both
the general polyubiquitin antibody and the K63-polyubiquitin
antibody revealed a high molecular weight smear only in anti-
CD3-activated D10 cells expressing Bcl10-GFP (Figure 2B).
These data therefore support previous observations that Bcl10
is K63 polyubiquitinated in response to TCR ligation (Wu and
Ashwell, 2008).
Selective autophagy of K63-polyubiquitinated proteins is
mediated by one of several known autophagy adaptor proteins.
Interestingly, p62 is both an autophagy adaptor and a protein
implicated in promoting NF-kB activation downstream of various
receptors (Moscat and Diaz-Meco, 2009), including the TCR
(Martin et al., 2006). We therefore performed several ex-
periments to assess whether POLKADOTS are sites of interac-
tion between p62- and K63-polyubiquitinated Bcl10. First, we
immunoprecipitated Bcl10-GFP from unstimulated and anti-
CD3-stimulated D10 T cells. Immunoblotting revealed that
although Bcl10-MALT1 association was relatively insensitive toImmunity 36, 947–958, June 29, 2012 ª2012 Elsevier Inc. 949
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Figure 2. K63-Polyubiquitinated Bcl10 Interacts with p62
(A) D10 T cells expressing Bcl10-CFP and MALT1-YFP were stimulated for 20 min with anti-CD3, followed by staining with anti-polyubiquitin, anti-K48-
polyubiquitin, or anti-K63-polyubiquitin.
(B) Unstimulated or anti-CD3-stimulated D10 T cells with or without Bcl10-GFP were lysed and heated at 95C for 5 min with 1% SDS to disrupt protein-protein
interactions. Bcl10-GFP was immunoprecipitated with anti-GFP, followed by immunoblot analysis to detect Bcl10-GFP ubiquitination.
(C) D10 T cells expressing or not expressing Bcl10-GFP were stimulated with anti-CD3 for the indicated times and lysed. Bcl10-GFP was recovered by
immunoprecipitation with anti-GFP, followed by immunoblot analysis with the indicated antibodies to detect Bcl10 binding partners.
(D) Confocal microscopy analysis of D10 T cells expressing Bcl10-CFP, MALT1-YFP, RFP-LC3, with 0 or 20 min anti-CD3 stimulation, to assess colocalization
between proteins.
(E) CD4+ Th2 cells expressing Bcl10-GFP were stimulated for the indicated times with anti-CD3+anti-CD28. Cells were stained with anti-p62 and anti-CD4, and
confocal microscopy was used to assess colocalization between Bcl10 and p62.
(F) D10 T cells expressing Bcl10-CFP and MALT1-YFP, with or without RFP-LC3, were stimulated for the indicated times with anti-CD3. Cells were lysed and
RFP-LC3 was immunoprecipitated, via anti-RFP. Immunoblotting with the indicated antibodies was used to detect LC3 binding partners. Asterisk indicates
position of Ig heavy chain. WCL, whole cell lysates; Ub, ubiquitin.
Scale bars represent 10 mm. Data representative of two (B, C, F) or three (A, D, E) independent experiments. See also Figure S2.
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ulation (Figure 2C). We next used confocal microscopy to visu-
alize endogenous p62 in D10 T cells expressing Bcl10-CFP,
MALT1-YFP, and RFP-LC3. As expected, in unstimulated
T cells, p62 showed primarily a punctate distribution950 Immunity 36, 947–958, June 29, 2012 ª2012 Elsevier Inc.(p62 ‘‘speckles’’), as a result of the self-aggregation that is
induced by the N-terminal PB1 domain (Moscat and Diaz-
Meco, 2009). Upon anti-TCR stimulation, we observed p62
speckles colocalizing with autophagosomes (RFP-LC3) and
Bcl10+Malt1 POLKADOTS (Figure 2D). We also confirmed these
Immunity
Autophagy Regulates TCR Activation of NF-kBdata by expressing YFP-tagged p62 in D10 T cells and observing
colocalization of YFP-p62 and Bcl10-CFP POLKADOTS after
anti-CD3 stimulation (Figure S2A). We obtained similar results
with CD4+ Th2 cells, in which we observed cytosolic p62
speckles colocalizing with Bcl10-GFP POLKADOTS, after anti-
CD3+anti-CD28 stimulation (Figure 2E). Endogenous Bcl10
also showed similar colocalization with endogenous p62 in
CD4+ Th2 cells (Figure S2B). Additionally, we observed Bcl10-
GFP association with p62 in response to antigen+APC stimula-
tion (Figure S2C). Finally, antibody staining data showed that
endogenous NBR1, another autophagy adaptor that can oligo-
merize with p62 (Kirkin et al., 2009a), also colocalized with
Bcl10-GFP POLKADOTS (Figure S2D).
Previous studies have suggested that p62 interacts with Malt1
and that Malt1 can be K63 polyubiquitinated in TCR-dependent
manner (Du¨wel et al., 2009; Martin et al., 2006). Thus, published
data suggest that polyubiquitination of either Bcl10 or Malt1 (or
both proteins) could account for the intense K63-polyubiquitin
labeling of POLKADOTS and the association with p62. However,
the fact that Bcl10, but not Malt1, was rapidly degraded after
TCR activation suggested that only Bcl10 enters the autophagy
pathway. Therefore, to ascertain whether Bcl10 and not MALT1
interacts with autophagosomes, we immunoprecipitated LC3
from lysates of D10 T cells, with an RFP antibody. As expected,
p62 coimmunoprecipitated with RFP-LC3 in lysates from both
stimulated and unstimulated T cells, showing that p62 constitu-
tively binds LC3 (Figure 2F). In contrast, Bcl10 coimmunopreci-
pitated with RFP-LC3 only after anti-CD3 stimulation. These
data suggest that a TCR-dependent process, such as K63 poly-
ubiquitination of Bcl10, is required to promote Bcl10 interaction
with p62 and LC3. Importantly, we failed to detect MALT1 in the
RFP-LC3 immunoprecipitates, consistent with the observation
that there is no appreciable degradation of Malt1 in response
to TCR engagement. Because Bcl10 andMalt1 are constitutively
associated within T cells (see also Figure 2C; Thome et al., 2010)
and there was no detectable Malt1 in complexes contain-
ing LC3, p62, and Bcl10 (Figure 2F), our data suggest that
a highly selective mechanism targets Bcl10 for association
with autophagosomes. Together, the data in Figure 2 suggest
that, in response to TCR signaling, Bcl10 is K63 polyubiquiti-
nated and physically associates with p62 speckles and LC3+
autophagosomes.
Expression of p62 Is Required for TCR-Dependent Bcl10
Degradation
To assess whether p62 plays a role in Bcl10 degradation, D10
cell lines expressing Bcl10-GFP were infected with either the
empty shRNA vector or a p62-shRNA (p62-silenced) (Figure 3A).
We stimulated these cell lines with anti-CD3 (0 and 2 hr) and
quantified Bcl10-GFP via flow cytometry. Although control cells
showed a substantial decrease in Bcl10-GFP fluorescence in
response to anti-CD3 stimulation, Bcl10-GFP fluorescence re-
mained unchanged in the p62-silenced cells (Figure 3B). We
then performed confocal microscopy experiments to assess
NF-kB activation by identifying cells with RelA nuclear transloca-
tion. In the absence of stimulation, control and p62-silenced cells
showed diffuse Bcl10 and cytosolic RelA, as expected. After
20 min of anti-CD3 stimulation, Bcl10 formed POLKADOTS in
control cells, while remaining diffusely localized in p62-silencedcells. Also, RelA translocated to the nucleus in control cells,
whereas it remained cytosolic in p62-silenced cells. At
120 min, control cells had greatly reduced Bcl10 fluorescence,
reflecting Bcl10 degradation, whereas Bcl10 fluorescence re-
mained unchanged in p62-silenced cells, consistent with flow
cytometry data. Also, we continued to observe RelA in the
nucleus in control cells, whereas RelA remained cytosolic
in the p62-silenced cell line (Figure 3C). Quantification of data
in the Figure 3C experiment revealed a significant decrease in
both cells forming Bcl10 POLKADOTS and cells with nuclear
RelA in the p62-silenced line. Moreover, those p62-silenced cells
that formed Bcl10 POLKADOTS were the same cells that
exhibited RelA nuclear translocation (Figures 3D and 3E and
data not shown). Staining with anti-p62 revealed that the small
percentage of p62-silenced cells with Bcl10 POLKADOTS
retained detectable amounts of p62 that colocalized with
POLKADOTS (Figure S3A).
To exclude the possibility that the observed phenotypes in the
p62-silenced cell line were due to an unrecognized general
defect in TCR signal transduction, we assessed phosphorylation
of the kinases ERK1 and ERK2, which are activated via a TCR-
dependent mechanism that is distinct from the NF-kB cascade
(Smith-Garvin et al., 2009). Although TCR-dependent Bcl10
degradation occurred in control cells and not in p62-silenced
cells, similar ERK1 and ERK2 phosphorylation was observed in
both cell lines (Figure S3B). Finally, we assessed whether p62
acts upstream or downstream of the IkB kinase complex (IKK),
which initiates terminal NF-kB activation via promoting degrada-
tion of IkBa. We stimulated D10 T cells or a D10 p62-silenced cell
line with anti-CD3 and measured phosphorylation of IKKa+IKKb
and degradation of endogenous Bcl10 by immunoblotting.
Whereas unmanipulated D10 T cells exhibited both Bcl10 degra-
dation and robust phosphorylation of the IKK complex in
response to anti-CD3, there was little to no IKK phosphorylation
or Bcl10 degradation in p62-silenced cells (Figure S3C). Thus,
consistent with previous data (Martin et al., 2006), this ex-
periment shows that p62 acts upstream of IKK in the TCR-to-
NF-kB pathway. Taken together, the data in Figures 3 and S3
show that expression of p62 in T cells is necessary for both
TCR-dependent activation of NF-kB and TCR-directed degrada-
tion of Bcl10.
Polyubiquitination of Bcl10 Is Required for Bcl10
Degradation
A recent study with Jurkat cells has established that polyubiqui-
tination of human Bcl10 occurs at lysines 31 and 63 (Wu and
Ashwell, 2008). Furthermore, blockade of Bcl10 polyubiquitina-
tion by mutation of these residues to arginines dramatically
inhibits TCR-mediated NF-kB activation and Bcl10 degradation
(Wu and Ashwell, 2008). To confirm these data, we expressed
GFP-tagged wild-type and K31R,K63R (KK.RR) Bcl10 in the
D10 Th2 T cell clone. Cells were stimulated for 0 or 20 min
with anti-CD3, followed by immunoprecipitation of Bcl10-
GFP. Immunoblotting revealed K63 polyubiquitination of wild-
type Bcl10 and greatly reduced polyubiquitination of the
Bcl10-KK.RR mutant (Figure 4A). The KK.RR mutant was also
deficient in NF-kB activation (as assessed by degradation of
IkBa), consistent with previous observations (Wu and Ashwell,
2008).Immunity 36, 947–958, June 29, 2012 ª2012 Elsevier Inc. 951
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Figure 3. p62 Silencing Inhibits RelA Nuclear Translocation and Blocks Bcl10 Degradation
(A) D10 T cells expressing Bcl10-GFP plus either mir30 shRNA vector or mir30 p62shRNA were analyzed by immunoblotting to detect p62 expression.
(B–E) D10 T cells expressing Bcl10-GFP plus mir30 shRNA vector or mir30 p62shRNAwere stimulated with anti-CD3 for the indicated times. Cells were analyzed
by flow cytometry to detect degradation of Bcl10-GFP (B) or stainedwith anti-RelA and theDNA dyeDRAQ5 and analyzed by confocal microscopy to assessRelA
nuclear translocation (C). Graphs showing percentage of cells in (C) forming Bcl10-GFP clusters (POLKADOTS) (D) or with RelA nuclear translocation (E).
(F) D10 T cells expressing Bcl10-GFP plus mir30 shRNA vector or mir30 p62shRNA were stimulated for 20 min with anti-CD3 and stained with anti-p62. p62
silencing and p62-Bcl10 colocalization were assessed by confocal microscopy.
Means (±SEM) were calculated by counting at least 20 cells from each of three experiments. Scale bars represent 10 mm. Data are representative of two (A, B) or
three (C, F) independent experiments. See also Figure S3.
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expressing wild-type Bcl10-GFP formed POLKADOTS at
20min and exhibited substantial loss of Bcl10-GFP fluorescence
by 120 min, the KK.RR mutant showed no TCR-dependent
change in distribution or fluorescence (Figure 4B). Examination
of the ERK pathway in both cell lines showed equivalent anti-
CD3-induced phosphorylation of both ERK1 and ERK2, confirm-
ing intact TCR signaling in both cell lines (Figure S4). Confocal
microscopy analysis showed that wild-type Bcl10 colocalized
with p62 clusters at 20 min poststimulation, whereas the
KK.RR mutant failed to translocate to p62 clusters (Figure 4C).
The data in Figures 4A–4C collectively suggest that K63 polyubi-
quitination of Bcl10 is essential for the Bcl10-p62 interaction and
Bcl10 degradation.
To more directly establish a requirement for Bcl10 polyubiqui-
tination for association between p62 and autophagosomes, we
immunoprecipitated wild-type and KK.RR Bcl10-GFP, assess-
ing the association of each form of Bcl10 with p62 and the
autophagosomemembrane proteins LC3 and Atg5-12. Immuno-952 Immunity 36, 947–958, June 29, 2012 ª2012 Elsevier Inc.blotting showed that wild-type Bcl10 associated with p62, LC3,
and Atg5-12 in response to anti-CD3 stimulation. However, the
polyubiquitination-deficient Bcl10-KK.RR mutant failed to asso-
ciate with both p62 and autophagosomes in response to stimu-
lation (Figures 4D and 4E). Together, the data in Figure 4 suggest
that modification of Bcl10 by K63 polyubiquitination mediates
Bcl10 association with p62 and autophagosomes.
TCR-Dependent Autophagy Is a Mechanism of Bcl10
Degradation
To specifically assess the effect of the autophagy-lysosomal
degradation pathway on Bcl10 degradation, we employed three
pharmacological agents that block this pathway at differing
points and by distinct mechanisms: 3-methyladenine (3-MA),
a type III PI3-kinase inhibitor that suppresses autophagosome
formation (Seglen and Gordon, 1982); Bafilomycin A1 (BafA1),
which blocks the H+ATPase pump, thereby preventing acidifi-
cation of lysosomes and/or lysosome-autophagosome fusion
(Klionsky et al., 2008); and E64d, an inhibitor of lysosomal
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Figure 4. Inhibition of Bcl10 K63 Polyubiquitination
Blocks Bcl10 Clustering and Degradation
(A) Unstimulated or anti-CD3-stimulated D10 T cells ex-
pressing either wild-type or the K31R,K63R mutant of
Bcl10-GFP (Bcl10-WT-GFP and Bcl10-KK.RR-GFP, re-
spectively) were lysed and heated at 95C in 1% SDS for
5 min to disrupt protein complexes. Bcl10-GFP was
immunoprecipitated with anti-GFP, followed by immuno-
blotting analysis to detect Bcl10 ubiquitination.
(B and C) D10 T cells expressing either Bcl10-WT-GFP
or Bcl10-KK.RR-GFP were stimulated for the indicated
times with anti-CD3 and analyzed by confocal micros-
copy. Cells were assessed for redistribution of Bcl10-GFP
in POLKADOTS (B) and for Bcl10-p62 colocalization via
staining with anti-p62 (C).
(D and E) D10 T cells expressing either Bcl10-WT-GFP or
Bcl10-KK.RR-GFP were stimulated for the indicated times
with anti-CD3, followed by lysis and immunoprecipitation
with anti-GFP. Immunoblotting was used to detect Bcl10
association with LC3 (D) and with p62 and Atg5-12 (E).
Asterisk indicates position of Ig heavy chain. Scale bars
represent 10 mm. Data are representative of two (A, D, E) or
three (B, C) experiments. See also Figure S4.
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with inhibitors, we used flow cytometry to quantify Bcl10-GFP at
0 hr and 2 hr after anti-CD3 stimulation. There was no effect of
inhibitors on Bcl10-GFP in the absence of stimulation. After
anti-CD3 stimulation, control cells pretreated with vehicle ex-
hibited a clear decrease in Bcl10-GFP median fluorescence
intensity (MFI), reflecting degradation of Bcl10-GFP, while all
three drug treatments inhibited Bcl10 degradation (Figure 5A).
The partial effect of all three drugs on Bcl10 proteolysis sug-
gested that the proteasome may also contribute to Bcl10 degra-
dation. Indeed, p62 can direct ubiquitinated proteins to both
the autophagy-lysosome pathway and the proteasome (Moscat
et al., 2009; Seibenhener et al., 2004). To assess the potential
role of the proteasomal pathway on Bcl10 degradation, we
pretreated D10 T cells with the proteasomal inhibitor MG132,
followed by 0 hr or 2 hr anti-CD3 stimulation. Flow-cytometry
analysis revealed a partial block of Bcl10 degradation, similar
to the effects of autophagy inhibitors (Figure 5B). Analogous
effects on Bcl10 degradation were observed when the same
inhibitors were used with C57BL/6 Th2 cells expressing Bcl10-
GFP (Figure 5C).Immunity 36To confirm the specificity of the chemical
inhibitors of autophagy, we employed a genetic
approach. Specifically, we in vitro differentiated
Th2 cells from mice in which the essential au-
tophagy gene, Atg3, can be conditionally inacti-
vated (Jia and He, 2011). Atg3 deletion was
induced in Th2 cells via 4-hydroxytamoxifen
(4-OHT) treatment. After 2 hr stimulation with
anti-CD3+anti-CD28, we compared the degree
of Bcl10 degradation between WT control
(Atg3f/f) and Atg3-deleted (Atg3f/f ER-Cre) cells,
in the presence and absence of MG132 (Fig-
ure 5D). Whereas control cells (Atg3f/f) exhibited
robust degradation of endogenous Bcl10, much
less Bcl10 degradation occurred in Th2 cellslacking ATG3. Moreover, although MG132 treatment partially
blocked Bcl10 degradation in the Atg3f/f control cells, the
residual Bcl10 degradation in cells lacking ATG3 was completely
or nearly completely blocked by MG132 treatment. These data
provide strong genetic evidence that TCR-mediated degrada-
tion of endogenous Bcl10 is controlled by autophagy, with
a contribution from the proteasomal system.
TCR-Dependent Autophagy Is Responsible
for Separating Bcl10 from Malt1
To assess the effect of autophagy inhibitors on the subcellular
distribution of Bcl10, we pretreated D10 T cells expressing
Bcl10-CFP, MALT1-YFP, and RFP-LC3 with 3-MA or BafA1.
We then stimulated cellswith anti-CD3 for 20min or 2 hr, followed
by confocal microscopy analysis. Consistent with data in Figures
1 and 2, untreated controls exhibited colocalization between
Bcl10- and Malt1-containing POLKADOTS and LC3 puncta at
20 min poststimulation (Figure 5E). By 120 min poststimulation,
control cells showed depletion of Bcl10-GFP and concentration
of the remaining Malt1 in large aggregates. Cells treated with
BafA1 exhibited a phenotype indistinguishable from controls, 947–958, June 29, 2012 ª2012 Elsevier Inc. 953
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Figure 5. Blockade of Autophagy Prevents TCR-Dependent Bcl10 Degradation
(A and B) D10 T cells expressing Bcl10-GFP were pretreated with distilled water (control), DMSO (vehicle control), the autophagy inhibitor 3-methyladenine
(3-MA), or the lysosomal degradation inhibitors Bafilomycin A1 (BafA1) and E64d (A) or the proteasomal inhibitor MG132 (B) and stimulated for the indicated times
with anti-CD3. Bcl10-GFP degradation was assessed by flow cytometry. Histograms are representative data from one experiment and bar graphs are mean
(±SEM) of Bcl10-GFP median fluorescence intensity (MFI) from three independent experiments.
(C) The experiment of (A) and (B) was repeated with primary Th2 cells.
(D) Primary Th2 cells expressing (Atg3f/f) or not expressing (Atg3f/f ER-Cre) ATG3 were pretreated with vehicle (control) or MG132, followed anti-CD3+anti-CD28
stimulation for the indicated times. Endogenous Bcl10, tubulin, and ATG3 were detected by immunoblotting. Asterisk indicates nonspecific band.
(E) D10 T cells expressing Bcl10-CFP, MALT1-YFP, and RFP-LC3 were pretreated with DMSO (control), BafA1, or 3-MA, followed by anti-CD3 stimulation. Cells
were imaged by confocal microscopy to assess colocalization between proteins.
Data are representative of two independent experiments. Scale bar represents 10 mm.
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ated with LC3+ puncta in BafA1-treated cells. Importantly, most
of the cellular Malt1 no longer colocalized with the Bcl10 puncta,
forming aggregates within the cell that were clearly distinct from
the Bcl10+LC3+ aggregates. In the case of 3-MA treatment, we
observed normal formation of Bcl10- and Malt1-containing
POLKADOTS at 20 min, but very weak formation of LC3+ auto-
phagosomes, consistent with expectations. At 120 min, there
was little evidence of Bcl10 degradation, and Bcl10 remained
tightly associated with the large Malt1 aggregate.
Combinedwith thedata of Figures 1, 2, 3, and4, thedata in Fig-
ure 5E suggest a sequential process by which Bcl10 becomes
associated with p62, captured by LC3+ autophagosomes, and
degraded via the autophagy-lysosomepathway: TCRstimulation
leads toK63polyubiquitination of Bcl10. Via the ubiquitin-binding
(UBA) domain of p62, Bcl10 becomes concentrated at p62
speckles, and the resulting p62-Bcl10 clusters efficiently
promote signal transduction to IKK. Simultaneously, via interac-
tionwith theLC3 interaction region (LIR) of p62, autophagosomes
assemble at p62 speckles, engulfing K63-polyubiquitinated
Bcl10, modulating signals from Bcl10 to IKK. Bcl10 is then
degradedwithin autophagosomes (with contributions by the pro-
teasome), leaving aggregates of Malt1 that coalesce over time.954 Immunity 36, 947–958, June 29, 2012 ª2012 Elsevier Inc.The autophagy of Bcl10 was mechanistically associated with
the physical separation of Bcl10 and Malt1, as demonstrated
by the existence of spatially distinct Bcl10+LC3+ puncta and
larger aggregates containing Malt1 (and not Bcl10), subsequent
to BafA1 treatment. In other words, in both untreated and BafA1-
treated cells, autophagosomes engulf Bcl10, without capturing
Malt1. BafA1 treatment inhibits a later degradative step, blocking
autophagosome-lysosome fusion and/or lysosomal acidifica-
tion, thereby leaving Bcl10 enclosed within LC3+ vesicles at
120 min. By contrast, when autophagosome formation is
blocked by 3-MA, Bcl10 is not captured from the p62 speckles
by autophagosomes. Thus, in the absence of autophagosome
formation, Bcl10 and Malt1 are never physically separated,
remaining colocalized during the coalescence of Malt1 aggre-
gates. Overall, the data in Figure 5E suggest that autophagy is
an essential component of the mechanism that separates
Bcl10 fromMalt1, enabling the selective TCR-dependent degra-
dation of Bcl10.
Inhibition of Autophagy Enhances TCR-Mediated NF-kB
Activation
A prediction of the above model is that 3-MA treatment or Atg3
deletion should leave a signaling-competent form of Bcl10
A B
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D E
Figure 6. Blockade of Autophagy Enhances TCR-Mediated NF-kB Activation
(A) D10 T cells expressing Bcl10-GFP plus an integrated 53 NF-kB Gaussia luciferase reporter were pretreated with indicated inhibitors. Cells were stimulated
with anti-CD3 for the indicated times, and supernatants were harvested. Graph shows mean secreted luciferase activity (±SEM).
(B) CD4+ Th2 cells were pretreated with the indicated compounds and stimulated with anti-CD3+anti-CD28 for the indicated times. Cells were analyzed by flow
cytometry to measure induction of CD25 expression after gating on the CD4-positive population (>90%). Histograms are representative data from one exper-
iment and bar graphs are means (±SEM) of anti-CD25 fluorescence generated from three independent experiments.
(C) The experiment of (B) was repeated with CD8+ Tcm cells, and secreted IL-2 was measured by XTT assay. Bar graphs are means ± SEM.
(D) Primary Th2 cells expressing (Atg3f/f) or not expressing (Atg3f/f ER-Cre) ATG3 were stimulated for 6 hr with anti-CD3+anti-CD28 and analyzed by flow
cytometry for CD25 expression.
(E) The experiment of (D) was repeated with CD8+ Tcm cells, and secreted IL-2 was measured by XTT assay. Bar graphs are means ± SEM.
Data are representative of two independent experiments (C–E).
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engagement. In contrast, BafA1 and E64d treatment should
not block the autophagy of Bcl10, but rather its later degradation
by the lysosome. Consequently, the Bcl10 that becomes en-
gulfed within autophagosomes in BafA1- and E64d-treated cells
should be unable to signal to NF-kB because it is not accessible
to downstream cytoplasmic signaling partners. Thus, 3-MA
treatment and Atg3 deletion should enhance signaling to
NF-kB, whereas BafA1 and E64d treatment should have no
impact on signaling to NF-kB. We tested these predictions in
several independent assays. First, we generated a D10 cell line
expressing both Bcl10-GFP and a Gaussia luciferase reporter
gene under control of an NF-kB-dependent promoter. After
drug pretreatment, we stimulated this cell line by using anti-
CD3. Prior to anti-CD3 stimulation, there was generally no effect
of the inhibitors, although we noted a modest increase in basal
NF-kB activity after treatment with the autophagy inhibitor
3-MA. After 6 hr of anti-CD3 stimulation, 3-MA-pretreated cells
exhibited significantly increased NF-kB activity (approximately
3-fold greater than control). In contrast, lysosomal inhibitors
did not significantly impact NF-kB activity in anti-CD3-treated
cells (Figure 6A).
As a second approach, we pretreated in vitro differentiated
Th2 cells with 3-MA, BafA1, E64d, and MG132. Cells were
treated for 0 hr or 6 hr with anti-CD3+anti-CD28 and assessed
by flow cytometry for expression of CD25, a gene highly depen-
dent on NF-kB activation and Bcl10 expression (Ballard et al.,1988; Kingeter and Schaefer, 2008; Ruland et al., 2001).
Whereas 3-MA-pretreated cells showed a significantly higher
increase in anti-CD3-induced CD25 expression compared to
control cells, the increase in CD25 expression after BafA1 and
E64d pretreatment was indistinguishable from controls (Fig-
ure 6B). MG132, in addition to inhibiting Bcl10 degradation,
also prevents proteasomal degradation of IkBa, thereby inhibit-
ing the terminal step leading to NF-kB activation (Palombella
et al., 1994). As expected, there was no upregulation of CD25
in MG132-pretreated cells (Figure 6B). As a third approach, we
measured IL-2 secretion from CD8+ Tcm cells. After pretreat-
ment with the same inhibitors employed in Figure 6B, CD8+
Tcm cells were stimulated with anti-CD3+anti-CD28 for 0 hr or
6 hr, and the amount of IL-2 (also highly NF-kB and Bcl10 depen-
dent) (Hoyos et al., 1989; Kingeter and Schaefer, 2008; Ruland
et al., 2001) was measured in cell supernatants. Similar to the
results of Figure 6B, treatment with the lysosomal degradation
inhibitors BafA1 and E64d had little impact on IL-2 secretion,
whereas inhibition of NF-kB activation by MG132 treatment pre-
vented IL-2 secretion. Only inhibition of autophagy by 3-MA led
to increased IL-2 production in response to anti-CD3 stimulation
(Figure 6C).
To confirm that the 3-MA data truly reflect inhibition of auto-
phagy and not an off-target effect of this drug, we also tested
the effect of Atg3 deletion on anti-CD3+anti-CD28 induction of
CD25 expression by Th2 cells as well as the production of IL-2
by Tcm cells (Figures 6D and 6E). These data confirmed that cellsImmunity 36, 947–958, June 29, 2012 ª2012 Elsevier Inc. 955
Immunity
Autophagy Regulates TCR Activation of NF-kBlacking ATG3 (Atg3f/f ER-Cre) showed higher expression
of CD25 and greater production of IL-2 than WT control
cells (Atg3f/f). Taken together, the data in Figure 6 show that
TCR signaling to NF-kB is augmented by inhibition of the
autophagy-lysosomal degradation pathway prior to autopha-
gosome formation. Inhibition of later steps (autophagosome-
lysosome fusion and lysosomal proteolytic activity) has no
impact on NF-kB signaling. These data are therefore consistent
with the predictions described above.
DISCUSSION
In this study, we have shown that selective autophagy is a major
mechanism of TCR-dependent degradation of Bcl10. Our data
are consistent with our previous fluorescence resonance energy
transfer (FRET) study, showing a time-dependent dissociation of
Bcl10 and Malt1 specifically within the POLKADOTS structures
(Rossman et al., 2006). Indeed, Malt1, a constitutive binding
partner of Bcl10, is not destroyed in this autophagy process,
but remains in aggregates that coalesce over time into a much
larger structure (Rossman et al., 2006). Previous data suggest
that Bcl10 phosphorylation plays a role in dissociating Bcl10-
Malt1 complexes (Wegener et al., 2006). However, even if
Bcl10 phosphorylation has a profound effect on the avidity of
the Bcl10-Malt1 interaction, it is unclear how Malt1 avoids
engulfment by autophagosomes while remaining localized at
a site that cannot be distinguished (by conventional confocal
microscopy) from the site of autophagosome engulfment of
Bcl10. How then is Bcl10 selectively targeted for autophagy,
when both proteins are clearly in close proximity to p62 during
the capture of Bcl10 by autophagosomes? This complex mech-
anistic question will require much future work.
Importantly, we found that p62 is crucial both for Bcl10-
dependent NF-kB activation and for termination of Bcl10 sig-
naling, via promoting Bcl10 autophagy. Our previous FRET
data indicated that Bcl10 signaling partners are enriched at
POLKADOTS (Rossman et al., 2006), so K63 polyubiquitination
of Bcl10 may promote association with and activation of down-
stream signaling partners by creating Bcl10 clusters that serve
as cytosolic signaling platforms. Via the p62-LC3 association,
autophagy depleted K63-polyubiquitinated Bcl10 from these
signaling platforms, reducing activating signals to NF-kB. It will
be important to determine how the formation of Bcl10 signaling
complexes and the termination of signaling by Bcl10 autophagy
are orchestrated to yield the observed kinetics of NF-kB activa-
tion and deactivation downstream of TCR engagement (Kingeter
et al., 2010).
Additionally, we found that Bcl10 degradation is confined to
effector T cells. This observation may reflect the fact that naive
T cells, in contrast to effector T cells, require an extended period
of TCR signaling to successfully proliferate (Iezzi et al., 1998).
Thus, the observed increase in Bcl10 expression in naive
T cells may be necessary for these cells to achieve the precise
amount of NF-kB activation required for successful completion
of G1. Conversely, in effector T cells, the degradation of Bcl10
may be necessary to temporally limit stimulation to the time
period during which NF-kB signals promote T cell activation
and cell cycle entry. This homeostatic mechanism may further-
more protect effector T cells from undesired consequences of956 Immunity 36, 947–958, June 29, 2012 ª2012 Elsevier Inc.inappropriate activation of NF-kB in later phases of the cell cycle,
such as induction of senescence (Zhi et al., 2011) or apoptosis
(Iezzi et al., 1998).
A growing body of data implicates selective autophagy in
diverse cellular processes such as degradation of toxic protein
aggregates and processing antigens for presentation to T cells
(Kirkin et al., 2009b; Kraft et al., 2010; Levine et al., 2011).
However, we are aware of only one previous study of higher
eukaryotes that has identified a role of selective autophagy in
directly regulating a signal transduction pathway as part of
normal cellular physiology. A recent publication suggests that
selective autophagy of disheveled (Dvl) negatively regulates the
Wnt pathway (Gao et al., 2010). Multiple aspects of this regula-
tory mechanism are strikingly similar to the NF-kB regulatory
pathway we have described. For example, the autophagy of
Dvl is facilitated by p62, and binding to p62 requires Dvl ubiqui-
tination. Additionally, degradation of Dvl is partially sensitive to
MG132, indicating that the proteasome can participate in degra-
dation of ubiquitinated Dvl.
There is also a notable difference between the autophagy-
dependent destruction of Dvl and Bcl10. Specifically, data
suggest that the destruction of Dvl is initiated by cell stressors,
such as starvation, and is therefore not triggered as an integral
process within the Wnt pathway. By contrast, in the case of
TCR-to-NF-kB signaling, our data indicate that antigen signaling
through the TCR triggers both activation of NF-kB and the
selective autophagy of Bcl10, inhibiting NF-kB activation. In
other words, these findings strongly suggest that Bcl10 auto-
phagy is an integrated homeostatic mechanism allowing the
TCR to very precisely control the magnitude and/or kinetics of
NF-kB activation in effector T cells. The existence of such a
regulatory mechanism is consistent with our recent observation
that the TCR-to-NF-kB cascade is digital, with the amount of
NF-kB activation in individual T cells being remarkably invariant,
regardless of the intensity of TCR signals (Kingeter et al., 2010).
In general terms, our data demonstrate that selective autophagy
can serve as a built-in homeostatic mechanism by which
a receptor precisely controls the extent of activation of a target
transcription factor.
Overall, our data establish a molecular mechanism whereby
signaling to NF-kB is negatively modulated by TCR-induced
autophagy of Bcl10. Our data suggest that Bcl10 degradation
is mediated by p62-dependent selective targeting of K63-
polyubiquitinated Bcl10 for entry into the autophagy-lysosomal
proteolysis system. Combined with the recent report of re-
gulation of the Wnt pathway by a similar selective autophagy
process, our data suggest that selective autophagy may be a
common mechanism for modulation of diverse signaling path-
ways. Indeed, while this manuscript was in revision, a report
was published describing an autophagy mechanism that limits
inflammasome activation in macrophages by a very similar
p62- and polybiquitin-mediated process (Shi et al., 2012).
EXPERIMENTAL PROCEDURES
Cell Lines and Reagents
D10 T cells were maintained as previously described (Rossman et al.,
2006). Pretreatments with inhibitors were as follows: 3-methyladenine
(MP Biomedicals) in distilled water (1 mM), 16 hr; Bafilomycin A1 (Enzo Life
Sciences) in DMSO (100 nM), 1 hr; E64d (Cayman chemicals) in DMSO
Immunity
Autophagy Regulates TCR Activation of NF-kB(10 mg/ml), 16 hr; and MG132 in DMSO (20 mM), 1 hr. Antibodies are detailed
in Supplemental Experimental Procedures.
CD8+ Tcm and CD4+ Th2 Cell Differentiation
Lymph nodes and spleens were collected from C57BL/6, Atg3f/f, or Atg3f/f
ER-Cre mice (Jia and He, 2011). Negative bead sorting of CD4+ and CD8+
T cells, CD8+ Tcm cell differentiation, and CD4+ Th2 cell differentiation were
performed as described (Fitch et al., 2006; Kingeter and Schaefer, 2008;
Manjunath et al., 2001). Deletion of Atg3 via 4-OHT treatment was as
described (Jia and He, 2011). All mouse experiments were approved by the
Uniformed Services University Institutional Animal Care and Use Committee.
Flow Cytometry for Detection of Bcl10-GFP Degradation
D10 T cells or CD4+ Th2 cells or CD8+ Tcm cells (5 3 105) expressing
Bcl10-GFP were stimulated with plate-bound anti-CD3 (D10) or anti-CD3+
anti-CD28 (primary T cells), pelleted by centrifugation, and fixed with 3% form-
aldehyde. Flow cytometry was performed with BD LSRII flow-cytometer, as
described (Kingeter and Schaefer, 2008). Data were analyzed with Flowjo
software (TreeStar).
Confocal Microscopy and Pearson’s Colocalization Analysis
Fixation and staining of T cells was as previously described (Rossman et al.,
2006). Confocal images were obtained with a 403 1.4 NA oil objective, a Zeiss
710 NLO microscope, and Zen software. LSM files were exported to Adobe
Photoshop for cropping and adjusting contrast levels. POLKADOTS were
scored through visual observation of Bcl10 clusters. Nuclear RelA was scored
with visual observation of RelA signal overlapping with nuclear DRAQ5 signal.
Quantification of colocalization was performed with the Intensity Correlation
Analysis plugin in MBF ImageJ (http://www.macbiophotonics.ca/imagej).
30 cells in each group were analyzed to generate the Pearson’s correlation
coefficient with a range of +1 (perfect correlation) to 1 (perfect exclusion).
Immunoprecipitation and Immunoblotting
D10 T cells were stimulated as described (Rossman et al., 2006). Cells were
incubated on ice for 30 min in a lysis buffer (Wu et al., 2006) with 13 Halt
protease inhibitor cocktail (PierceBiotechnology) and 5mMN-ethylmaleimide.
Precleared lysates were incubated with anti-GFP (MP Biomedicals) or anti-
RFP (Rockland) overnight at 4C. Antibody-antigen complexes were then
captured with protein G sepharose beads (GE). Bcl10 ubiquitination was
detected as described (Wu and Ashwell, 2008). In brief, after cell lysis, 1%
SDS was added to the lysates and heated for 5 min at 95C. Lysates were
diluted to a concentration of 0.1% SDS, followed by overnight immunoprecip-
itation with anti-GFP. Immunoblotting was performed as described (Rossman
et al., 2006).
Gaussia Luciferase and XTT Assays
For NF-kB luciferase assays, supernatants from 5 3 105 cells/condition were
collected at 6 hr poststimulation and Luciferase activity was measured with
a Gaussia Luciferase kit (Targeting Systems). For IL-2 assays, supernatants
from 53 105 cells/condition were collected at 6 hr poststimulation and added
to 96-well plates loaded with 5,000 HT-2 cells/well. HT-2 cells were grown for
48 hr, followed by addition of XTT to measure viability (Biotium). Absorbance
(OD) was measured with a spectrometer at 490 nm. Measured OD was con-
verted to ng/ml IL-2 by linear regression, employing a standard curve and
Graph Pad Prism 4.0.
Statistical Analysis
For Figure 3, p values were calculated with an unpaired two-tailed t test. For
Figures 6A–6C and 6E, p values for the difference in mean between controls
and treated cells were calculated by one-way ANOVA with Dunnett’s Multiple
comparison post-test.
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